EUVIMEDEUVIMED entdecken
Crossref

Replacing the tropolonic methoxyl group of colchicine with methylamino increases tubulin binding affinity with improved therapeutic index and overcomes paclitaxel cross-resistance

Juanjuan Yang, Dake Song, Bingqian Li, Xiaoxiao Gao, Yuetong Wang, Xiaohu Li, Changshun Bao, Caijiao Wu, Yu Bao, Samuel Waxman, Guoliang Chen, Yongkui Jing

Drug Resistance Updates · 2023

DOI: 10.1016/j.drup.2023.100951 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Resistance Updates, 2023. Verfasst von Juanjuan Yang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Liaoning Key Laboratory of Targeting Drugs for Hematological Malignancies, Department of Pharmacology, Shenyang Pharmaceutical University, Shenyang 1…. Hauptthemen laut MEDLINE: Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: Shenyang Pharmaceutical University, Samuel Waxman Cancer Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsAntineoplastic AgentsHumansPaclitaxelColchicineTubulinVincristineCell Line, Tumor

Stichwörter der Autor:innen

AminocolchicineDrug resistancePaclitaxelStructural modificationTubulin binding

Substanzen

PaclitaxelColchicineTubulinVincristineAntineoplastic Agents

Autor:innen und Institutionen

  • Liaoning Key Laboratory of Targeting Drugs for Hematological Malignancies, Department of Pharmacology, Shenyang Pharmaceutical University, Shenyang 110016, China.
  • Key Laboratory of Structure-Based Drugs Design & Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China.
  • The Division of Hematology/Oncology, Department of Medicine, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York 10029, USA.
  • Key Laboratory of Structure-Based Drugs Design & Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China. Electronic address: chenguoliang@syphu.edu.cn.
  • Liaoning Key Laboratory of Targeting Drugs for Hematological Malignancies, Department of Pharmacology, Shenyang Pharmaceutical University, Shenyang 110016, China. Electronic address: Jingyk@syphu.edu.cn.

Förderung

  • Shenyang Pharmaceutical University
  • Samuel Waxman Cancer Research Foundation

Zitieren

APA

Yang, J., Song, D., Li, B., Gao, X., Wang, Y., Li, X., Bao, C., Wu, C., Bao, Y., Waxman, S., Chen, G., & Jing, Y. (2023). Replacing the tropolonic methoxyl group of colchicine with methylamino increases tubulin binding affinity with improved therapeutic index and overcomes paclitaxel cross-resistance. Drug Resistance Updates. https://doi.org/10.1016/j.drup.2023.100951

Vancouver

Yang J, Song D, Li B, Gao X, Wang Y, Li X, et al. Replacing the tropolonic methoxyl group of colchicine with methylamino increases tubulin binding affinity with improved therapeutic index and overcomes paclitaxel cross-resistance. Drug Resistance Updates. 2023. doi:10.1016/j.drup.2023.100951

BibTeX
@article{Yang2023,
  author = {Yang, Juanjuan and Song, Dake and Li, Bingqian and Gao, Xiaoxiao and Wang, Yuetong and Li, Xiaohu and Bao, Changshun and Wu, Caijiao and Bao, Yu and Waxman, Samuel and Chen, Guoliang and Jing, Yongkui},
  title = {Replacing the tropolonic methoxyl group of colchicine with methylamino increases tubulin binding affinity with improved therapeutic index and overcomes paclitaxel cross-resistance},
  journal = {Drug Resistance Updates},
  year = {2023},
  doi = {10.1016/j.drup.2023.100951}
}
Kostenlos starten →